Tycho Peterson
Stock Analyst at JP Morgan
(5.00)
# 1
Out of 4,856 analysts
131
Total ratings
63.04%
Success rate
270%
Average return
Main Sectors:
Stocks Rated by Tycho Peterson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Overweight | $160 → $155 | $116.74 | +32.77% | 8 | May 29, 2025 | |
| WGS GeneDx Holdings | Upgrades: Buy | $80 | $72.42 | +10.47% | 1 | May 9, 2025 | |
| QDEL QuidelOrtho | Upgrades: Buy | $44 | $30.21 | +45.65% | 6 | May 8, 2025 | |
| MTD Mettler-Toledo International | Upgrades: Hold | $1,200 → $1,100 | $1,195.39 | -7.98% | 8 | May 5, 2025 | |
| DHR Danaher | Maintains: Overweight | $280 → $260 | $199.20 | +30.52% | 3 | Apr 22, 2025 | |
| LH Labcorp Holdings | Maintains: Buy | $275 → $290 | $255.73 | +13.40% | 2 | Feb 6, 2025 | |
| NEO NeoGenomics | Initiates: Buy | $22 | $7.56 | +191.01% | 1 | Dec 10, 2024 | |
| DGX Quest Diagnostics | Assumes: Buy | $185 | $175.90 | +5.17% | 1 | Dec 10, 2024 | |
| HOLX Hologic | Initiates: Hold | $85 | $64.57 | +31.64% | 7 | Dec 10, 2024 | |
| QGEN Qiagen | Assumes: Buy | $43 → $56 | $46.17 | +20.47% | 5 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $355 → $415 | $348.33 | +19.14% | 7 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $35 | $33.36 | +4.92% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $125 | $92.88 | +34.58% | 1 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $10.09 | +137.86% | 7 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.20 | +233.33% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $5 → $3 | $0.77 | +290.02% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $142 | $164.19 | -13.51% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $49.53 | -35.39% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $115 | $84.98 | +35.33% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Underperform | $25 → $20 | $5.19 | +285.36% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $600 → $650 | $408.53 | +59.11% | 12 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $26 → $9 | $12.36 | -27.18% | 1 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.54 | - | 2 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 → $12 | $2.20 | +445.45% | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $60 | $5.06 | +1,085.77% | 2 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $2.86 | +704.20% | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $375 → $390 | $147.46 | +164.48% | 5 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $1.12 | +1,953.57% | 1 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $2.87 | +528.27% | 1 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $188 → $200 | $526.15 | -61.99% | 9 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $24 | $19.02 | +26.18% | 3 | Jun 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $65 → $45 | $16.23 | +177.35% | 5 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $70 | $131.68 | -46.84% | 2 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $120 | $154.15 | -22.15% | 1 | Feb 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $1.28 | - | 7 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $39.21 | - | 5 | Nov 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $55 | $16.15 | +240.56% | 1 | Jul 19, 2016 | |
Agilent Technologies
May 29, 2025
Maintains: Overweight
Price Target: $160 → $155
Current: $116.74
Upside: +32.77%
GeneDx Holdings
May 9, 2025
Upgrades: Buy
Price Target: $80
Current: $72.42
Upside: +10.47%
QuidelOrtho
May 8, 2025
Upgrades: Buy
Price Target: $44
Current: $30.21
Upside: +45.65%
Mettler-Toledo International
May 5, 2025
Upgrades: Hold
Price Target: $1,200 → $1,100
Current: $1,195.39
Upside: -7.98%
Danaher
Apr 22, 2025
Maintains: Overweight
Price Target: $280 → $260
Current: $199.20
Upside: +30.52%
Labcorp Holdings
Feb 6, 2025
Maintains: Buy
Price Target: $275 → $290
Current: $255.73
Upside: +13.40%
NeoGenomics
Dec 10, 2024
Initiates: Buy
Price Target: $22
Current: $7.56
Upside: +191.01%
Quest Diagnostics
Dec 10, 2024
Assumes: Buy
Price Target: $185
Current: $175.90
Upside: +5.17%
Hologic
Dec 10, 2024
Initiates: Hold
Price Target: $85
Current: $64.57
Upside: +31.64%
Qiagen
Dec 10, 2024
Assumes: Buy
Price Target: $43 → $56
Current: $46.17
Upside: +20.47%
Oct 8, 2024
Upgrades: Buy
Price Target: $355 → $415
Current: $348.33
Upside: +19.14%
Aug 5, 2024
Maintains: Underweight
Price Target: $28 → $35
Current: $33.36
Upside: +4.92%
Jul 29, 2024
Maintains: Hold
Price Target: $115 → $125
Current: $92.88
Upside: +34.58%
Jul 22, 2024
Upgrades: Buy
Price Target: $24
Current: $10.09
Upside: +137.86%
Jun 3, 2024
Initiates: Buy
Price Target: $4
Current: $1.20
Upside: +233.33%
Jun 3, 2024
Assumes: Hold
Price Target: $5 → $3
Current: $0.77
Upside: +290.02%
Jun 3, 2024
Initiates: Buy
Price Target: $142
Current: $164.19
Upside: -13.51%
Jun 3, 2024
Initiates: Buy
Price Target: $32
Current: $49.53
Upside: -35.39%
Jun 3, 2024
Assumes: Hold
Price Target: $115
Current: $84.98
Upside: +35.33%
Jun 3, 2024
Assumes: Underperform
Price Target: $25 → $20
Current: $5.19
Upside: +285.36%
Jun 3, 2024
Assumes: Buy
Price Target: $600 → $650
Current: $408.53
Upside: +59.11%
Sep 21, 2022
Downgrades: Underweight
Price Target: $26 → $9
Current: $12.36
Upside: -27.18%
Aug 16, 2022
Downgrades: Neutral
Price Target: n/a
Current: $3.54
Upside: -
Aug 11, 2022
Downgrades: Neutral
Price Target: $20 → $12
Current: $2.20
Upside: +445.45%
Mar 2, 2022
Maintains: Overweight
Price Target: $85 → $60
Current: $5.06
Upside: +1,085.77%
Aug 17, 2021
Initiates: Overweight
Price Target: $23
Current: $2.86
Upside: +704.20%
May 28, 2021
Maintains: Overweight
Price Target: $375 → $390
Current: $147.46
Upside: +164.48%
May 11, 2021
Initiates: Overweight
Price Target: $23
Current: $1.12
Upside: +1,953.57%
Aug 10, 2020
Initiates: Neutral
Price Target: $18
Current: $2.87
Upside: +528.27%
Jun 18, 2020
Maintains: Overweight
Price Target: $188 → $200
Current: $526.15
Upside: -61.99%
Jun 1, 2020
Maintains: Overweight
Price Target: $22 → $24
Current: $19.02
Upside: +26.18%
Mar 17, 2020
Maintains: Neutral
Price Target: $65 → $45
Current: $16.23
Upside: +177.35%
Nov 2, 2018
Maintains: Overweight
Price Target: $60 → $70
Current: $131.68
Upside: -46.84%
Feb 15, 2018
Maintains: Overweight
Price Target: $115 → $120
Current: $154.15
Upside: -22.15%
Dec 13, 2017
Downgrades: Underweight
Price Target: n/a
Current: $1.28
Upside: -
Nov 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $39.21
Upside: -
Jul 19, 2016
Initiates: Neutral
Price Target: $55
Current: $16.15
Upside: +240.56%